 Experimental treatment benign prostatic hyperplasia transurethral balloon dilation prostate preliminary study humans prospective study safety potential efficacy transurethral balloon catheter dilation prostate TUDP treatment benign prostatic hyperplasia BPH subjects moderate symptoms signs prostatism basis quantitative symptom score SS uroflowmetry measurements residual urine volume Seven patients urinary retention Mean age years range years TUDP patients significant complications Mean follow-up months range months Forty-six patients improved SS recent follow-up patients SS prostatectomy subjects Reduction mean residual urine volume significant patients median lobe enlargement improvement SS others authors TUDP safe effectiveness ultimate demonstration effectiveness controlled clinical trial